1 glutinin for each antigen (40 percent of the usual dose), and 119 to receive an intramuscular injecti

2 from folic acid supplementation taken at the usual doses are no greater than small.

3                               In patients on usual dose lipid-lowering medication (n = 1,910) there w

4 ically manifest vascular disease using no or usual dose lipid-lowering medication, low plasma HDL-C l

5 ing that platelet doses of half to twice the usual dose of 2.2 x 10(11) platelets/transfusion/body su

6 et doses in ranges between half to twice the usual dose of 2.2 x 10(11) platelets/transfusion/BSA hav

7 s in TIMI 3 flow when combined with half the usual dose of alteplase.

8 s, patients were randomly administered their usual dose of CsA with either 8 ounces of grapefruit jui

9               Patients received either their usual dose of levothyroxine (n = 23) or combination ther

10 four adults were vaccinated with 1/50 of the usual dose of meningococcal polysaccharide vaccine (1 mi

11 L-C on vascular events in patients using no, usual dose, or intensive lipid-lowering therapy.

12 emental treatment effect of high-dose versus usual-dose statin therapy in individual coronary artery

13 ts for whom the benefits of high-dose versus usual-dose statin therapy outweigh potential harm.